Medicinal cannabis: is a new light showing for patients with psychiatric disorders?

Authors

DOI:

https://doi.org/10.20453/rnp.v84i3.4042

References

Huarcaya-Victoria J. Consideraciones sobre la salud mental en la pandemia de COVID-19. Rev Peru Med Exp Salud Publica. 2020; 37(2): 327-334. DOI: 10.17843/rpmesp.2020.372.5419

Khan R, Naveed S, Mian N, Fida A, Raafey MA, Aedma KK. The therapeutic role of Cannabidiol in mental health: a systematic review. J Cannabis Res. 2020;2(1):2. doi: 10.1186/s42238-019-0012-y

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiol Psychiatr Sci. 2018;27(4):327-335. doi: 10.1017/ S2045796018000239

Muñoz JF. El cannabidiol y sus indicaciones en psiquiatría. Medicina UPB. 2021; 40(1): 65-76. DOI: 10.18566/medupb.v40n1.a09

Graczyk M, Łukowicz M, Dzierzanowski T. Prospects for the use of cannabinoids in psychiatric disorders. Front Psychiatry. 2021; 12: 276.

Downloads

Published

2021-10-13

How to Cite

1.
Cevallos-Zelada V. Medicinal cannabis: is a new light showing for patients with psychiatric disorders?. Rev Neuropsiquiatr [Internet]. 2021 Oct. 13 [cited 2024 Jul. 3];84(3):249-50. Available from: https://revistas.upch.edu.pe/index.php/RNP/article/view/4042

Issue

Vol. 84 No. 3 (2021): July-September

Section

LETTERS TO THE EDITOR